We are live on
!
Find out more
Charles River Laboratories
CRL
CRL
413 hedge funds and large institutions have $7.23B invested in Charles River Laboratories in 2019 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 146 increasing their positions, 139 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
251% more call options, than puts
Call options by funds: $38.5M | Put options by funds: $11M
85% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 34
17% more capital invested
Capital invested by funds: $6.19B → $7.23B (+$1.04B)
4% more funds holding
Funds holding: 396 → 413 (+17)
5% more repeat investments, than reductions
Existing positions increased: 146 | Existing positions reduced: 139
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.1% less ownership
Funds ownership: 96.97% → 96.87% (-0.1%)
Holders
413
Holders Change
+17
Holders Change %
+4.29%
% of All Funds
8.14%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
63
Increased
146
Reduced
139
Closed
34
Calls
$38.5M
Puts
$11M
Net Calls
+$27.5M
Net Calls Change
+$26.9M
Top Buyers
| 1 |
Millennium Management
New York
|
+$63.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.9M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$38M |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$29.2M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$21.8M |
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$46.4M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$32.1M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
-$29.6M |
| 4 |
HM
HealthCor Management
New York
|
-$26.4M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$22.6M |
